News Digest 20.11.2023-22.11.2023
Regulators
Roszdravnadzor suspended the use of a medical system with AI
For the first time, Roszdravnadzor suspended the use of a medical product with artificial intelligence (AI) - the Botkin.AI analysis system, which allows doctors to detect pathologies in computed tomography images. The department considered that the development, created through investments from a pool of venture funds, including Rosatom, the Ministry of Industry and Trade, R-Pharm, Tashira, could “cause harm to the health” of patients. Three years ago, the developer of the system, Intellogik, announced its integration into medical institutions in Moscow, but the mayor’s office claims that they do not use it. To train AI to identify pathologies, serious technical solutions are required, which clinics are not yet ready for, experts say.
Source: https://www.kommersant.ru/doc/6350252
Market news
3.7 billion rubles will be allocated for the purchase of mobile medical complexes
The Government of the Russian Federation has allocated 3.7 billion rubles to continue the program for the purchase of mobile medical complexes (MMC) for rural areas, urban settlements and small towns with a population of up to 50 thousand people. In total, 250 units of secondary battery will be delivered to 67 regions at the end of 2023 and beginning of 2024. Compared to last year, the volume of purchases increased by 35%. In 2022-2023, the only suppliers of the complexes were PKF Luidor and LLC Trading House Vorsma.
The Moscow region authorities will centrally purchase stents and catheters for 1.207 billion rubles
The Committee on Competition Policy of the Moscow Region announced a tender for the purchase of consumables for endovascular surgery for the needs of the vascular departments of ten hospitals in the region. In total, it is planned to purchase 1,720 types of stents, catheters, syringes, conductors and other medical products. The initial maximum contract price is set at 1.207 billion rubles.
Rosatom intends to increase production of the Tianox medical system from 2024
Rosatom plans to almost double the production of the innovative Russian medical system Tianox for nitric oxide therapy from 2024. This was stated by Deputy Scientific Director of the RFNC-VNIIEF, Corresponding Member of the Russian Academy of Sciences Viktor Selemir at the congress “Innovative technologies for the use of medical gases in modern clinical practice,” writes the nuclear industry newspaper “Rosatom Country”. “The RFNC-VNIIEF (Rosatom enterprise) assembles 300 devices a year. But demand is growing - starting next year they plan to produce 500 devices, and when a production complex is built in Sarov - 1-2 thousand,” the publication quotes the scientist as saying.
Source: https://tass.ru/ekonomika/19330519
The shipment of medical products using the second offset worth 11.7 billion rubles has begun
The winner of the offset bid for the supply of absorbent underwear and diapers for the needs of the capital's social institutions - a subsidiary of the Turkish manufactory UCAR Group, the VIP Camilla company - has begun localizing products in Moscow at a site in the Rudnevo industrial park.
The first batch of products has already been shipped. The company won the contract for 11.7 billion rubles in January 2023. According to the terms of the agreement, the company must invest at least 300 million rubles in creating production and attract at least 70 employees.
In 2011, the Turkish holding invested in a factory for the production of diapers under the Senso brand in Belarus. Since 2022, the company has been a supplier of Belarusian products for Russian medical institutions.
Source: https://www.mos.ru/news/item/132417073/
Other
Technology for preimplantation genetic testing for cystic fibrosis has been developed in Tomsk
Scientists and doctors from the Genetic Clinic and Research Institute of Medical Genetics of the Tomsk National Research Medical Center of the Russian Academy of Sciences have developed a technology for preimplantation genetic testing (PGT) for cystic fibrosis. A panel of genetic markers makes it possible to identify a severe hereditary disease even before pregnancy, during the procedure of in vitro fertilization (IVF), the press service of the National Research Medical Center reported on November 20.
Robotic assistants - robot cats - have appeared in the capital's hospitals
Robot couriers began helping doctors and patients in pilot mode in three metropolitan hospitals. Because of their appearance with cat ears and eyes, they are called robot cats. Robots can perform a variety of tasks: delivering food and medicine, greeting and escorting patients, helping them transport things, and giving health advice. Robocats are absolutely safe to use. Cameras help them navigate in space. Two of them at the bottom scan the environment 90 times per second, another one is aimed at the ceiling. The robots are equipped with 3D sensors, so they can stop in front of any obstacle and always maintain a safe distance (even during sudden braking). They work for a day without recharging.
Source: https://www.mos.ru/news/item/132424073/
News
